GLUT12 functions as a basal and insulin-independent glucose transporter in the heart

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 1, 2013, Pages 121-127

  Waller, Amanda P ^a   George, Michael ^a   Kalyanasundaram, Anuradha ^a   Kang, Chen ^a   Periasamy, Muthu ^a   Hu, Keli ^a   Lacombe, Véronique A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Exofacial bis mannose photolabeling; GLUT translocation; Myocytes; Perfused myocardium

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 12; GLUCOSE TRANSPORTER 4; INSULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DOWN REGULATION; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; IMMUNOFLUORESCENCE MICROSCOPY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 1; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; MICE; MYOCARDIUM;

RODENTIA;

EID: 84868517764     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.09.013     Document Type: Article

References (34)

1. Abel E.D. Glucose transport in the heart. Front. Biosci. 2004, 9:201-215.
2. Meigs J.B., Nathan D.M., D'Agostino R.B., Wilson P.W. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002, 25:1845-1850.
3. Fang Z.Y., Prins J.B., Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 2004, 25:543-567.
4. Bryant N.J., Govers R., James D.E. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 2002, 3:267-277.
5. Katz E.B., Stenbit A.E., Hatton K., DePinho R., Charron M.J. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995, 377:151-155.
6. Thorens B., Mueckler M. Glucose transporters in the 21st Century. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E141-E145.
7. Stuart C.A., Howell M.A., Zhang Y., Yin D. Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. J. Clin. Endocrinol. Metab. 2009, 94:3535-3542.
8. Purcell S.H., Aerni-Flessner L.B., Willcockson A.R., Diggs-Andrews K.A., Fisher S.J., Moley K.H. Improved insulin sensitivity by GLUT12 overexpression in mice. Diabetes 2011, 60:1478-1482.
9. Rogers S., Macheda M.L., Docherty S.E., Carty M.D., Henderson M.A., Soeller W.C., Gibbs E.M., James D.E., Best J.D. Identification of a novel glucose transporter-like protein-GLUT 12. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E733-E738.
10. Ware B., Bevier M., Nishijima Y., Rogers S., Carnes C.A., Lacombe V.A. Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R1300-R1306.
11. Waller A.P., Burns T.A., Mudge M., Belknap J., Lacombe V.A. Insulin resistance selectively alters cell surface glucose transporters, but not their total protein expression, in equine skeletal muscle. J. Vet. Intern. Med. 2011, 25:315-321.
12. Waller A.P., Kohler K., Burns T.A., Mudge M., Belknap J., Lacombe V.A. Naturally-occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissue without change in AS160 activation. Biochim. Biophys. Acta Mol. Basis Dis. 2011, 1812:1098-1103.
13. Lacombe V.A., Hinchcliff K.W., Devor S.T. Effects of exercise and glucose administration on content of insulin-sensitive glucose-transporter in equine skeletal muscles. Am. J. Vet. Res. 2003, 64:1500-1506.
14. Koumanov F., Yang J., Jones A.E., Hatanaka Y., Holman G.D. Cell-surface biotinylation of GLUT4 using bis-mannose photolabels. Biochem. J. 1998, 330:1209-1215.
15. Miller E.J., Li J., Sinusas K.M., Holman G.D., Young L.H. Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1922-E1928.
16. Lacombe V.A., Viatchenko-Karpinski S., Terentyev D., Sridhar A., Emani S., Bonagura J.D., Feldman D.S., Gyorke S., Carnes C.A. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am. J. Physiol. 2007, 293:R1787-R1797.
17. Garg V., Jiao J., Hu K. Regulation of ATP-sensitive K1 channels by caveolin-enriched microdomains in cardiac myocytes. Cardiovasc. Res. 2009, 82:51-58.
18. Stenbit A.E., Tsao T.S., Li J., Burcelin R., Geenen D.L., Factor S.M., Houseknecht K., Katz E.B., Charron M.J. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat. Med. 1997, 3:1096-1101.
19. Stuart C.A., Yin D., Howell M.E., Dykes R.J., Laffan J.J., Ferrando A.A. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1067-E1073.
20. Fischer Y., Thomas J., Sevilla L., Munoz P., Becker C., Holman G.D., Kozka I.J., Palacin M., Testar X., Kammkermeier H., Zorzano A. Insulin-induced recruitment of glucose transporters Glut-4 and Glut-1 in isolated rat cardiac myocytes. Evidence for the existence of different intracellular Glut-4 vesicle populations. J. Biol. Chem. 1997, 272:7085-7092.
21. Davey K.A., Garlick P.B., Warley A., Southworth R. Immunogold labeling study of the distribution of GLUT-1 and GLUT-4 in cardiac tissue following stimulation by insulin or ischemia. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2009-H2019.
22. Laviola L., Belsanti G., Davalli A.M., Napoli R., Perrini S., Weir G.C., Giorgino R., Giorgino F. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes 2001, 50:2709-2720.
23. Huang J.P., Huang S.S., Deng J.Y., Hung L.M. Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats. J. Biomed. Sci. 2009, 16:77-90.
24. Russell R.R., Yin R., Caplan M.J., Xu X., Ren J., Shulman G.I., Sinusas A.J., Young L.H. Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation 1998, 98:2180-2186.
25. Yang C., Watson R.T., Elmendorf J.S., Sacks D.B., Pessin J.E. Calmodulin antagonists inhibit insulin-stimulated GLUT4 (Glucose Transporter 4) translocation by preventing the formation of phosphatidylinositol 3,4,5- trisphosphate in 3T3L1 adipocytes. Mol. Endocrinol. 2000, 14:317-326.
26. Hall J.L., Sexton W.L., Stanley W.C. Exercise training attenuates the reduction in myocardial GLUT-4 in diabetic rats. J. Appl. Physiol. 1995, 78:76-81.
27. Osborn B.A., Daar J.T., Laddaga R.A., Romano F.D., Paulson D.J. Exercise training increases sarcolemmal GLUT-4 protein and mRNA content in diabetic heart. J. Appl. Physiol. 1997, 82:828-834.
28. Stuart C.A., Howell M.E., Yin D. Overexpression of GLUT5 in diabetic muscle is reversed by pioglitazone. Diabetes Care 2007, 30:925-931.
29. Dimitrakoudis D., Vranic M., Klip A. Effects of hyperglycemia on glucose transporters of the muscle: use of the renal glucose reabsorption inhibitor phlorizin to control glycemia. J. Am. Soc. Nephrol. 1992, 3:1078-1091.
30. Lund S., Holman G.D., Zierath J.R., Rincon J., Nolte L.A., Clark A.E., Schmitz O., Pedersen O., Wallberg-Henriksson H. Effect of insulin on GLUT4 cell-surface content and turnover rate in human skeletal muscle as measured by the exofacial bis-mannose photolabeling technique. Diabetes 1997, 46:1965-1969.
31. Ryder J.W., Yang J., Galuska D., Rincón J., Björnholm M., Krook A., Lund S., Pedersen O., Wallberg-Henriksson H., Zierath Z.R., Holman G.D. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000, 49:647-654.
32. Stanley W.C., Recchia F.A., Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 2005, 85:1093-1129.
33. Rosenblatt-Velin N., Montessuit C., Papageorgiou I., Terrand J., Lerch R. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. Cardiovasc. Res. 2001, 52:407-416.
34. Stuart C.A., Howell M.E., Baker J.D., Dykes R.J., Duffourc M.M., Ramsey M.W., Stone M.H. Cycle training increased GLUT4 and activation of mammalian target of rapamycin in fast twitch muscle fibers. Med. Sci. Sports Exerc. 2010, 42:96-106.